QUALIGEN THERAPEUTICS, INC.
Profile
Company Names
QUALIGEN THERAPEUTICS, INC.
RITTER PHARMACEUTICALS INC
Addresses
5857 OWENS AVENUE, SUITE 300, CARLSBAD, CA 92008
5857 OWENS AVENUE,, SUITE 300,, CARLSBAD,, CA 92008
1880 CENTURY PARK EAST, SUITE 1000, LOS ANGELES, CA 90067
1801 CENTURY PARK EAST, SUITE 1820, LOS ANGELES, CA 90067
1801 CENTURY PARK EAST, #1820, LOS ANGELES, CA 90067
1880 CENTURY PARK EAST, SUITE 1100, LOS ANGELES, CA 90067
10100 SANTA MONICA BLVD, #2430, LOS ANGELES, CA 90067
Phone Numbers
(760) 452-8111
310-203-1000
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY, PHARMACEUTICALS, OTHER HEALTH CARE
Year Incorporated:
2008
State Incorporated:
DELAWARE
Total Amount Raised:
$28,889,803.00
Number of Funding Rounds:
9
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
9
2025-07-28
$4,500,000.00
$4,500,000.00
$0.00
Equity
8
2024-11-18
$5,100,000.00
$5,100,000.00
$0.00
Equity
7
2018-11-05
$6,000,000.00
$6,000,000.00
$0.00
Equity
6
2014-12-04
$3,693,875.00
$5,670,054.00
$1,976,179.00
Equity
5
2012-02-08
$526,445.00
$3,500,000.00
$2,973,555.00
Debt
4
2010-11-17
$7,366,914.00
$7,366,914.00
$0.00
Equity
3
2010-09-23
$250,000.00
$250,000.00
$0.00
Debt
2
2010-03-04
$452,569.00
$452,569.00
$0.00
Debt
1
2009-08-07
$1,000,000.00
$1,000,000.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
THOMAS
ADAMEK
DIRECTOR
CAMPBELL
BECHER
DIRECTOR, EXECUTIVE OFFICER
GRAYDON
BENSLER
DIRECTOR
NOAH
DOYLE
DIRECTOR
RITTER PHARMACEUTICALS INC
| QUEPLIX CORP.
| LAM AVIATION, INC.
| CAPECO, INC.
| JAVELIN VENTURE PARTNERS, L.P.
| ODDMOBB, INC.
| JAVELIN VENTURE PARTNERS II, L.P.
| XMOBB, INC.
| CORRELATED MAGNETICS RESEARCH, LLC
| JAVELIN II CMR AIV, L.P.
| JAVELIN II CMR AIVB, LLC
| APPFIRST, INC.
| SKYTREE, INC.
| KOPO KOPO INC.
| PIXALATE, INC.
| SOCIABLE LABS, INC.
| 8671192 CANADA INC.
| S LABS HOLDINGS, LLC
| OPUS DELI, INC.
| FEM, INC.
| VACATIA, INC.
| ESTIMOTE INC.
| JAVELIN VENTURE PARTNERS IV, L.P.
| WIZELY, INC.
| FUTURE LAB, INC.
| SEISMOS, INC.
| JAVELIN VENTURE PARTNERS I SPV II, LLC
| JAVELIN VENTURE PARTNERS I SPV I, LLC
| APPVANCE INC.
| JAVELIN VENTURE PARTNERS III SPV I, LLC
| JAVELIN VENTURE PARTNERS I SPV II-A, LLC
| JAVELIN VENTURE PARTNERS II SPV I, LLC
| UNIVERSE EXPLORATION CO
| JAVELIN VENTURE PARTNERS V, L.P.
| JAVELIN VENTURE PARTNERS III SPV II, LLC
| JAVELIN VENTURE PARTNERS III SPV III, LLC
| JAVELIN VENTURE PARTNERS V SPV I, LLC
| JAVELIN VENTURE PARTNERS V-A, L.P.
| JAVELIN VENTURE PARTNERS V-A SPV I, LLC
| JAVELIN VENTURE PARTNERS SPV IV-I, LLC
| JAVELIN VENTURE PARTNERS V-A SPV III, LLC
MATTHEW
W.
FOEHR
DIRECTOR
BRAEDEN
LICHTI
DIRECTOR
PAUL
V.
MAIER
DIRECTOR
ANDREW
RITTER
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2025-07-28
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2024-11-18
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2018-11-05
